3 R&D centres

Ipsen has set-up its R&D centres at the heart of three internationally reputed scientific hubs: Paris-Saclay in France, Oxford in the United Kingdom, and Cambridge in the United States. Each site is located close to leading academic research centres, cutting-edge medical centres and biotechnological companies. Interactions with key health industry players greatly increase our chances of access to innovative technologies to speed up the discovery and approval of drugs and services that improve the lives of patients.

 
Opened on April 1, 2015, the Ipsen Bioscience R&D centre in Cambridge is dedicated to a “search & evaluate” model to enhance the pipeline with clinical assets across all three therapy areas; Oncology, Neurology and Rare Diseases. In addition, it hosts key functions essential to the delivery of clinical projects to market: the development team, tasked with coordinating and conducting clinical research in North Americ and a dedicated regulatory group which focuses on Ipsen’s regulatory activities with the FDA in the United States.

It is located in an exceptional environment of universities and academic institutions, within one of the largest life sciences hubs. Ipsen’s researchers work in close proximity with top American universities and institutions (Harvard, Massachusetts Institute of Technology, etc.), prestigious hospitals and major players in pharmaceuticals, as well as pioneering start-ups, including some of Ipsen’s partners. The Cambridge facility positions Ipsen at the centre of the biotech revolution, among the most exciting pioneers in the industry.

> 13%

of sales invested in R&D in 2015

3

global R&D centres

~300

employees assigned to R&D

Date of preparation January 2018 / ALL-UK-000455